| Product Code: ETC8285745 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Parkinsons Disease Treatment Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Parkinsons Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Parkinsons Disease Treatment Market - Industry Life Cycle |
3.4 Mexico Parkinsons Disease Treatment Market - Porter's Five Forces |
3.5 Mexico Parkinsons Disease Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Mexico Parkinsons Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Parkinsons Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Mexico |
4.2.2 Rising awareness about treatment options and healthcare services |
4.2.3 Technological advancements in Parkinson's disease treatments |
4.2.4 Growing geriatric population in Mexico |
4.2.5 Favorable government initiatives and policies supporting healthcare infrastructure development |
4.3 Market Restraints |
4.3.1 High treatment costs associated with Parkinson's disease therapies |
4.3.2 Limited access to specialized healthcare services in certain regions of Mexico |
4.3.3 Regulatory challenges in drug approval processes |
4.3.4 Lack of skilled healthcare professionals specializing in Parkinson's disease management |
4.3.5 Stigma and social barriers related to neurological disorders |
5 Mexico Parkinsons Disease Treatment Market Trends |
6 Mexico Parkinsons Disease Treatment Market, By Types |
6.1 Mexico Parkinsons Disease Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By Carbidopa-Levodopa, 2021- 2031F |
6.1.4 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.1.5 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By MAO-B Inhibitors, 2021- 2031F |
6.1.6 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By COMT Inhibitors, 2021- 2031F |
6.1.7 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Parkinsons Disease Treatment Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.2.4 Mexico Parkinsons Disease Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Mexico Parkinsons Disease Treatment Market Import-Export Trade Statistics |
7.1 Mexico Parkinsons Disease Treatment Market Export to Major Countries |
7.2 Mexico Parkinsons Disease Treatment Market Imports from Major Countries |
8 Mexico Parkinsons Disease Treatment Market Key Performance Indicators |
8.1 Average waiting time for Parkinson's disease diagnosis and treatment |
8.2 Number of healthcare facilities offering specialized Parkinson's disease care |
8.3 Patient satisfaction rates with Parkinson's disease treatment services |
8.4 Adoption rate of new technologies in Parkinson's disease management |
8.5 Rate of adherence to Parkinson's disease treatment plans |
9 Mexico Parkinsons Disease Treatment Market - Opportunity Assessment |
9.1 Mexico Parkinsons Disease Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Mexico Parkinsons Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Parkinsons Disease Treatment Market - Competitive Landscape |
10.1 Mexico Parkinsons Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Mexico Parkinsons Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here